Literature DB >> 30481120

Correlates of Recent HIV Testing Among Transgender Women in Greater Kuala Lumpur, Malaysia.

Ronnye Rutledge1, Olga Morozova2, Britton A Gibson1, Frederick L Altice1,2,3, Adeeba Kamarulzaman1,3, Jeffrey A Wickersham1,3.   

Abstract

PURPOSE: In Malaysia, an estimated 9.7%-12.4% of transgender women (TW) are HIV positive, with higher estimates among those engaged in sex work. According to the 90-90-90 Joint United Nations Programme on HIV/AIDS strategy, HIV testing is the first crucial step in curbing the HIV epidemic. This study examines correlates of recent HIV testing among TW in Greater Kuala Lumpur, Malaysia.
METHODS: TW (N = 199) in Greater Kuala Lumpur completed a survey on healthcare access and utilization, including HIV testing history. Bivariate logistic regression and penalized multivariate logistic regression were used to explore correlates of HIV testing in the last 12 months.
RESULTS: Overall, 41.7% of TW reported having ever been tested for HIV. Among participants who were HIV negative or not sure of their HIV status (n = 187), only 18.7% (n = 35) had been tested for HIV in the last 12 months. The multivariate analysis indicated that having a primary care provider (PCP), being 26-40 years of age, and having higher mental health functioning were positively associated with recent HIV testing. Active amphetamine use and previous depression diagnosis were also associated with recent HIV testing.
CONCLUSION: HIV testing is the first step in linking individuals to prevention and treatment interventions. Our findings suggest that having a PCP can improve engagement in HIV testing. Moreover, PCPs can serve as a valuable link to HIV treatment and prevention services. Current interventions that target social and behavioral risk factors for HIV, on their own, may be insufficient at engaging all HIV-vulnerable TW.

Entities:  

Keywords:  HIV; HIV testing; Malaysia; trans woman; transgender women

Mesh:

Year:  2018        PMID: 30481120      PMCID: PMC6306652          DOI: 10.1089/lgbt.2018.0021

Source DB:  PubMed          Journal:  LGBT Health        ISSN: 2325-8292            Impact factor:   4.151


  33 in total

1.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity.

Authors:  J Ware; M Kosinski; S D Keller
Journal:  Med Care       Date:  1996-03       Impact factor: 2.983

2.  EBglmnet: a comprehensive R package for sparse generalized linear regression models.

Authors:  Anhui Huang; Dianting Liu
Journal:  Bioinformatics       Date:  2016-03-15       Impact factor: 6.937

3.  Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale.

Authors:  B E Berger; C E Ferrans; F R Lashley
Journal:  Res Nurs Health       Date:  2001-12       Impact factor: 2.228

Review 4.  Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis.

Authors:  Jeffrey S Gonzalez; Abigail W Batchelder; Cristina Psaros; Steven A Safren
Journal:  J Acquir Immune Defic Syndr       Date:  2011-10-01       Impact factor: 3.731

5.  Amphetamine use is associated with increased HIV incidence among men who have sex with men in San Francisco.

Authors:  Kate Buchacz; Willi McFarland; Timothy A Kellogg; Lisa Loeb; Scott D Holmberg; James Dilley; Jeffrey D Klausner
Journal:  AIDS       Date:  2005-09-02       Impact factor: 4.177

6.  Mental health treatment to reduce HIV transmission risk behavior: a positive prevention model.

Authors:  Kathleen J Sikkema; Melissa H Watt; Anya S Drabkin; Christina S Meade; Nathan B Hansen; Brian W Pence
Journal:  AIDS Behav       Date:  2010-04

7.  Reducing HIV risk among transgender women in Thailand: a quasi-experimental evaluation of the sisters program.

Authors:  Duangta Pawa; Rebecca Firestone; Sindh Ratchasi; Olivia Dowling; Yaowalak Jittakoat; Alex Duke; Gary Mundy
Journal:  PLoS One       Date:  2013-10-29       Impact factor: 3.240

Review 8.  The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices.

Authors:  Jae M Sevelius; Madeline B Deutsch; Robert Grant
Journal:  J Int AIDS Soc       Date:  2016-10-18       Impact factor: 5.396

9.  Integrated and Gender-Affirming Transgender Clinical Care and Research.

Authors:  Sari L Reisner; Asa Radix; Madeline B Deutsch
Journal:  J Acquir Immune Defic Syndr       Date:  2016-08-15       Impact factor: 3.731

10.  Dengue in Malaysia: Factors Associated with Dengue Mortality from a National Registry.

Authors:  Su May Liew; Ee Ming Khoo; Bee Kiau Ho; Yew Kong Lee; Mimi Omar; Vickneswari Ayadurai; Fazlina Mohamed Yusoff; Zailiza Suli; Rose Nani Mudin; Pik Pin Goh; Karuthan Chinna
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

View more
  4 in total

1.  Testing, Inequities and Vulnerability of Adolescents to Sexually Transmitted Infections.

Authors:  José Ricardo de Carvalho Mesquita Ayres; Gabriela Junqueira Calazans; Reinaldo José Gianini; Fernanda Cangussu Botelho; Macarena Urrestarazu Devincenzi; Renata Bellenzani; Valeria Nanci Silva; Gustavo Henrique de Oliveira Amorim
Journal:  J Community Health       Date:  2021-09-03

Review 2.  HIV Testing Strategies, Types of Tests, and Uptake by Men Who have Sex with Men and Transgender Women: A Systematic Review and Meta-analysis.

Authors:  Laio Magno; Marcos Pereira; Caroline Tianeze de Castro; Thais Aranha Rossi; Laylla Mirella Galvão Azevedo; Nathalia Sernizon Guimarães; Ines Dourado
Journal:  AIDS Behav       Date:  2022-08-19

3.  Willingness to Use HIV Self-Testing and Associated Factors Among Transgender Women in Malaysia.

Authors:  Roman Shrestha; Jonathan M Galka; Iskandar Azwa; Sin How Lim; Thomas E Guadamuz; Frederick L Altice; Jeffrey A Wickersham
Journal:  Transgend Health       Date:  2020-09-02

Review 4.  Intervening for HIV prevention and mental health: a review of global literature.

Authors:  Pamela Y Collins; Jennifer Velloza; Tessa Concepcion; Linda Oseso; Lydia Chwastiak; Christopher G Kemp; Jane Simoni; Bradley H Wagenaar
Journal:  J Int AIDS Soc       Date:  2021-06       Impact factor: 5.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.